Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $153.1100 (10.17%) ($153.1100 - $153.1100) on Tue. Mar. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.15% (three month average) | RSI | 53 | Latest Price | $153.1100(10.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND advances 0.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(58%) IWM(55%) IWC(54%) XBI(54%) | Factors Impacting LGND price | LGND will decline at least -2.575% in a week (0% probabilities). VIXM(-27%) UUP(-18%) VXX(-17%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.575% (StdDev 5.15%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $129.94(-15.13%) | Inflection Point | Yes | Resistance Level | $156.04 | 5 Day Moving Average | $145.39(5.31%) | 10 Day Moving Average | $148.08(3.4%) | 20 Day Moving Average | $156.04(-1.88%) | To recent high | -29.1% | To recent low | 69.7% | Market Cap | $2.461b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |